All Episodes

#182 - How to Lead When You Don't Know Where You Are Going: 4 Lessons from Ben Horowitz (Part 2 of 2)

#181 - When Things Fall Apart: 3 Lessons from Ben Horowitz on Leading Through the Struggle (Part 1 of 2)

EP 180: Eric Ries | Why Good Companies Go Bad After Success

EP 179: Joško Bobanović | Why Venture Capital Fights Human Instinct

#178 - The Elon Musk Method: 7 Rules for Building What the Market Thinks Is Impossible

EP 177: Alberto Chalon | Liquidity Before the IPO Window Opens

Alasdair Milton, KPMG | Why Precision Medicine Still Fails Patients (SPARK20 – 168)

#176 - Why Smart People Say Yes: 7 Lessons from Influence by Robert Cialdini

EP 175: Stefanie Schubert | Why Smart People Lose Negotiations Before They Start

EP 174: Wanwipa Siriwatwechakul | Funding the Next Industrial Era

EP 173: Bret Kugelmass | The West Bet on the Wrong Energy Future

#172 - Fast Forward Thinking: Why Most Investments Fail — And How Elite VCs Think Differently

EP 171 - Björn Cochlovius: Why Brilliant Biotech Breaks at Manufacturing

EP 170 - Jim Pulcrano: Why Most Venture Capital Fails And What Europe Still Gets Wrong

EP 169 - Why New Year’s Goals Fail by February - Even for Disciplined People

EP 168 - Alasdair Milton: The Innovation Inflection Point: Why 70% of Cures Never Reach Patients

#167: Pattern Breakers — 7 Laws Behind Category-Defining Companies

SPARK20 – 156: Janos Pasztor | The Climate Diplomat Who Refuses to Give Up on Humanity

EP 166 - Karl Nehammer: Why Europe Fails to Scale – And How the EIB Plans to Fix It

EP 165 – Jason Foster: 153 Rejections Later — What Every Founder Must Learn About Resilience

EP 164 - Kat Kozyrytska: AI in Pharma Is a Yesterday Problem – Why Ethical Frameworks Can’t Wait

#163: The NVIDIA Way — 7 Scaling Lessons from Jensen Huang’s Playbook

Marc Penkala | Why Being Wrong is the Secret to Venture Success (SPARK20 – 139)

EP 162 - Alex Oppenheimer: The Secret Investors Use Before Writing the First Check

EP 161 - Enis Hulli: VC Secrets Exposed: Why Only US-Based Startups Dominate (and How to Beat the Odds)

EP 160 - Vadim Fedotov: Elevate Your Wellbeing: How Data-Driven Choices Create Peak Performance

Angeli Möller | Building the Future of Health with Precision, Vision, and Heart (SPARK20 – 142)

#159: No Rules Rules — 7 Culture Principles That Made Netflix Unstoppable

EP 158 - Rafael Rosengarten: Why 90% of Cancer Drugs Fail — and the Radical AI Fix You’ve Never Heard Of

EP 157 - Fabrizio Conicella: Why Europe Keeps Losing the Next Breakthroughs in Medicine

EP 156 - Janos Pasztor: The Most Controversial Fix for Climate Change

#155: Ray Dalio’s Playbook — 7 Principles for Building Scalable, Resilient Companies

Suzanne Heywood | From Shipwreck to Boardroom Leadership (SPARK20 - 133)

EP 154 - Kristina Levan: Why Life-Saving Therapies Aren’t Reaching Patients—And How to Fix It

EP 153 - Christopher Uhde: The Biotech IPO Boom is Over. Now What?

EP 152 - Alex Dang: Billion-Dollar Bets: Why VC’s Best Decisions Go Against the Crowd

#151: Mastering Uncertainty – 7 Venture Secrets to Thriving in Chaos

Dan Bowyer: Rethinking Venture Capital with Superseed VC (SPARK 20 – 125)

EP 150: 2024 in Review: 9 Bold Steps Toward a Brighter 2025

EP 149: Marina Schmidt - How Do We Feed 10 Billion People Without Destroying the Planet?

Doerte Hirschberg: Investing in Climate Solutions and Transforming Industries (SPARK20 - 114)

#148: Think Long-Term, Thrive Always: 7 Lessons From Investing Titans

SPARK 20 - 109: Philipp Baaske, CEO of Nanotemper

EP 147: DC Palter - Why Startups Face the 'Pit of Hell': The Truth About Securing Funding

EP 146: Bio Europe - Will Europe’s Biotech Future Survive? Inside the Funding and Talent Exodus

EP 145: Shlomo Noy - Why Healthcare Innovation Fails Without the Right Strategy

#144: 9 Life-Changing Principles from Charlie Munger: Smarter Investing and Decision-Making

EP 143: Jordi Ferrer Rendé - Is Healthcare Destroying the Planet? The Shocking Truth About CO2 Emissions

EP 142: Angeli Moeller - Why AI Isn’t Transforming Healthcare Like It Should

EP 141: Alessandro Morra - How AI-Powered Robotics Will Transform Security—Are You Prepared for the Future?

#140: Customer Obsession Isn’t Enough—What Jeff Bezos Knows That Most Leaders Miss

EP 139 - Marc Penkala - Why European Startups Must Think Bigger: Lessons from a Top VC on Turning Failure into Fortune

#138: The PayPal Blueprint: How Vision Without a Business Model Nearly Sunk a Tech Giant

EP 137: Hampus Jakobsson - The Secret to Venture Success: Investing in People, Not Just Ideas

EP 136: Focus and Determination: Lessons from Dan Brisse's Sports and Business Career

#135: Empowering Innovators: 10 Lessons from The Innovators by Walter Isaacson

EP 134 - The Secret Sauce of California’s Biotech Success Revealed by Joe Panetta

MM 22: Solving Big Problems: Luis Pareras on Smart Investments

EP 133: Suzanne Heywood - From Shipwreck to Boardroom: How Education Transformed a Life of Adversity into Extraordinary Success

#132: Mastering Risk and Failure: Jeff Bezos' Blueprint for Success (Biography Review)

EP 131: 🚀 Fast Forward Thinking: Luis Pareras on Future and Science-Driven Innovation

Ep 130: Gergely Krajcsi - Is Venture Debt the Missing Piece in Your Startup's Funding Puzzle? (EIB's Expert Reveals All)

#129: Elon Musk Leadership Formula: Risk, Ambition, and the Cost of Success (Walter Isaacson Biography Review)

EP 128: Squire Servance - Beyond Profit: Venture Capital’s Key Role in Solving Health Disparities

MM21: Mastering Venture Capital in a Volatile Market: Insights from a Life Science Investor

MM20: Alarming Disparities Exposed: A VC's Take on Health Equity - Squire Servance, Syridex Bio

#127: Tim Cook's Apple: Leadership, Profit, Privacy, & Changing the World (Book Review)

EP 126: Owen Reynolds is Changing the Game: Risk, Returns, & the Future of Tech

EP125 - Dan Bowyer: Revolutionizing Ventures: Dan Bowyer's Blueprint for Disruptive Success

#124: From Zero to Billion: How Venture Capital Shapes Our World | 'The Power Law' Review

EP 123 - Navigating the New Era of European Innovation with David Dana

EP 122: Change-Makers of 2023: Discovering New Paths in Health, Technology, and Climate

SP 15: 2024 Vision: Amplifying Deep Tech Voices – Insights from Investors and Entrepreneurs on 'Beginner's Mind'

EP 121 - Matías Peire: How Can Latin America Revolutionize Global Biotech?

MM 19: Merry Christmas from Christian Soschner: Uniting Deep Tech with Timeless Wisdom

MM 18: Revolutionizing Mental Health: The Promise of Psychedelic Therapy with Matias Serebrinsky

EP 120: Matias Serebrinsky: Shaping the Future of Mental Health: AI, Psychedelics, and Beyond

#119: Kara Moore - Innovating the Future: New Jersey's Bold Leap with NJEDA

SP 14: Defying the Odds: Zuckerberg's Blueprint for Startup Resilience and Growth

MM 17: Daniel Vitt: Munich's Biotech Surge: The Untold Story Behind Europe's Innovation Hub

MM 16: 🔥 Philipp Baaske: Unlocking the Cure: The Race Against Time in Cancer Research

#118: Ash Ravikumar - Beyond the Collider: CERN's Blueprint for Startup Breakthroughs

MM15: Alexander Valtingojer - Unlocking the Metaverse's Potential: The Crypto-Fintech Fusion Entrepreneurs Need to Know!

SP 13: Christian Soschner - Why Top Entrepreneurs Don't Have a Plan B - And You Shouldn't Either!

#117: Jon Chee - Disrupt, Ask, Innovate: Inside Jon Chee's Mindset

MM 14: Prof. Alexander Wurzer - Why Most Digital Innovators Fail at Patenting Their Tech

SP 12: Andrew Huberman - 🚨 The Silent Crisis: Why 70% of the U.S. and Europe are Vitamin D Deficient 🚨

#116: Yair Reem - From Net Zero to Gigatons: The Extantia Capital Blueprint for Climate Tech Investing

MM 13: Samantha Dale Strasser - Revolutionizing Drug Discovery: The Startup That's Changing the Game

SP 11: Unlocking the Investor's Dilemma: Buffett & Munger's Wisdom from Berkshire Hathaway 2023 Meeting

#115: Daniel Vitt - Pioneering Patient Care: Dr. Daniel Vitt on the Future of Medicine

MM 12: Marco Schmidt - The Future of Drug Discovery: Biotx's Predictive AI Approach

SP 10: Warren Buffett's Wisdom on Emotional Discipline: Highlights from the 2023 Berkshire Hathaway Meeting

MM 11: Kimberley Miner - Climate Change: A NASA Expert's Solutions

MM10: Philipp Baaske - Believe, Invest, and Grow: A Conversation with NanoTemper's CEO

#114: Doerte Hirschberg: Revolutionizing Climate Tech Investments, Empowering Women, Venture Capital

SP 9: From Failure to Success: Lessons from NVIDIA's CEO Jensen Huang

MM 9: Tobias Silberzahn on Unlocking Mental Well-being: Sleep, Nutrition, Mobility, Fitness, and Purpose

#113: Kimberley Miner: A Climate Change Journey from Everest to NASA

MM 8: Brian Feroldi's Insight: Why Does the Stock Market Go Up?

MM7: Behind PayPal's Triumph: Jimmy Soni on Elon Musk, Peter Thiel, and the Paypal Mafia

MM 6: Sebastian Mallaby: The Art of Storytelling in Venture Capital

MM 5: Rich Masters - Investing in Biotech: Risks, Rewards, and Realities

#112: BIO's Rich Masters on the Future of Biotech and the International Convention

SP8: The Art of Successful Investing: Lessons from Mohnish Pabrai

#111: Colin McCann Reveals Game-Changing Vaccine Strategies at IVI

MM4: Philipp Baaske - From Science Fiction to Microgravity: Nanotemper's Journey to the International Space Station

SP 7: From Villains to Vision: Unlocking Elon Musk's Powerwall Presentation Genius

MM3: Jeevan Sunner - Powerful Voices: The Rise of Female Leaders in Tech and Venture Capital

#110: DC Palter - From Japan to Silicon Valley: A Unique Business Angel Journey

#109: Philipp Baaske's Journey: From Small Village to Biotech Entrepreneur

MM 2: The Shocking Truth Behind Declining Drug R&D Productivity with Dr. Jack Scannell

SP 6: Saving the World from Extinction: A Review of Andy Weir's 'Project Hail Mary

MM 1: Alex Zhavoronkov - Transforming Drug Discovery Forever: How AI Is Revolutionizing Medicine and Changing Lives!

#108: Alex Zhavoronkov - Revolutionizing Medicine: How AI Will Cure Aging

SP 5: Unleashing Your Creative Potential: Sol LeWitt's Timeless Advice to Eva Hesse

#107: Jack Scannell - Uncovering Drug Development Efficiency Secrets: The Science Behind Pharmaceutical Research

SP 4: Arnold Schwarzenegger's 6 Rules of Success: A Guide to Living Your Dreams

#106: Breaking Barriers: Jeevan Sunner's Journey as a Female VC

#105: Expert Insights on Biophysics and the Future of Drug Discovery: An Interview with Dr. Thomas Schubert of 2bind

#104: Revolutionizing Respiratory Antivirals: The Science behind G.ST Antivirals

#103: The Future of Aging Research: Insights from the Founder of the Swiss Society for Aging Research, Dr. Collin Y. Ewald

#102: Uncover the Hidden Strategies for Securing Funding and Achieving Impact in European Research

#101: Lina Toro and Mauricio Agudelo - Unlocking the Secrets of Precision Nutrition and AI in the Animal Protein Industry: Insights from BIALTEC's Founders

SP 3: Is ChatGPT The Future of Content Creation or The End of It? The Truth Behind The Hype

The Top 5 Most Downloaded Episodes: A Look Back at 100 Episodes of Success with Scientific Entrepreneurs and Investors

#99: Albert Missbichler - This was 2022 - A Year in Review - Part 3

#98: Beginner's Mind - Memorable Moments of 2022

SP2: Happy New Year 2023 - Thank you for your support

#97: Caroline E. Heil - This was 2022 - A Year in Review - Part II

#96: Kurt Höller - This was 2022 - Year in Review Part I

#95: Jimmy Soni - The Founders - The Story of Paypal and the Entrepreneurs who Shaped Silicon Valley

SP1: Merry Christmas 2022 to the Podcast Community

#94: Adrian Brodesser - Virtual Reality: A Game-Changer for the Future

#93: Thomas Schubert - The Role of Biophysics in Drug Development and Drug Discovery: What you Need to Know

#92: Sebastian Mallaby - The Power Law - A Brief History of Venture Capital

#91: Marco Schmidt - AI in Drug Discovery and Drug Development: What You Need to Know

#90: Brian Feroldi - Why Does the Stock Market go up?

#89: E Jane Caraway - Life Science in Georgia

#88: Jia En Chin, Shirley Lu, Thijs Spoor: New Opportunities for Biotechs in China

#87: Tuvik Beker - How to Start a Life Science Company in Israel and Raise Capital in Silicon Valley

#86: Tobias Silberzahn - What is the State of Health & Wellbeing in Europe

#85: Emily Mitchell - What You Need to Know About Decentralized Clinical Trials

#84: Samantha Dale Strasser - Pepper Bio, MIT, And the Eco-System in Boston

#83: Donna LaVoie - How to Tell Your Story in 15 Slides

#82: Irene Fialka - Inspiring Stories from 20 Years of Bringing Academic Innovation Into Business

#81: Astrid Woollard and Christian Niedermüller - The Future of Investments in Digital Assets

#80: Alexander Belcredi and Lorenzo Corsini - How to Create An Overnight Success As An Entrepreneur

#79: Jonathan Sporn - How Psychedelic Drugs Help Ease the Mental Health Burden in Society

#78: Gerda Redl - The Future of Life Science Patents

#77: Alexander Valtingojer - How to Invest in Digital Assets

#76: Rich Masters - How the Pandemic Changed the Conference Industry - Bio US 2022 in San Diego

#75: Lisa Stöger - Creating Connections Between StartUps and International Stakeholders

#74: Mark Herschberg - Why Networking and Leadership are Important Skills for Deeptech Entrepreneurs

#73: Bharat Kanodia - How to Value Unique Assets

#72: Stefan Sandström - How to do Business in Japan

#71: Heike Schoen - How To Rescue Your Clinical Trial When at Risk to Fail

#70: Bruno Montanari - How Venture Capital Supports Science And Innovation

#69: Prof. Collin Ewald - Molecular Mechanisms of Healthy Ageing

#68: Mauricio Agudelo and Lina María Toro - Sustainable Animal Nutrition

#67: Kai Lamottke - Bringing Innovation to Life Science From China & Europe

#66 - Martin Popilka, Denis Roio - This was 2021 - A year in Review 7/7

#65 - Paul Polterauer, Philipp Peinsold, Markus Raunig - This was 2021 - A year in Review 6/7

#64: Walter Stockinger, Yoni Falkson - This was 2021 - A Year in Review Part 5/7

#63: Albert Missbichler, Peter Llewellyn-Davies - This was 2021 - A Year in Review Part 4/7

#62: Christian Soschner, Johannes Sarx, Philipp Hainzl, Stefanie Rösel, Julia Resch - This was 2021 - A Year in Review Part 3/7

#61: Bettina Resl, Sascha Berger,Tilmann Buerckstuemmer, Thomas Moser, Kimberly Cornfield - This was 2021 - A Year in Review Part 2/7

#60: Astrid Woollard, Dusica Lukac, Matthias Tarasiewicz, Irénée Robin - This was 2021 - A Year in Review Part 1/7

#59: Sascha Berger - TVM Capital - A Perspective on The Life-Science-Eco-System in the US and Europe

#58: Bettina Resl - Trends in the Pharma Industry in the 21st Century

#57: Jaromír Zahrádka - Bridging Science and Business in the European Life Science Eco-System

#56: Ole Dammann - How to Do Clinical Research in Europe

#55: Peter Llewellyn-Davies - The Future of Life Science Entrepreneurship and Investment in Europe

#54: Oliver Mavher and Michael Deichsel - Crypto Trading and Taxes - The Past, The Present, and The Future

#53: Alexander Schwartz and Ingrid Kelly Spillman - The Future of Early-Stage Deep Tech Investments in Europe

#52: Caroline Heil - Driving the Future of Meat

#51: Saara Inkinen - The Future of Tech Transfer in a Post-Pandemic World

#50: Dimitrios Tzalis - Insights Into Building CROs in Asia and in Europe

#49: Andrea Sommer - Marrying Deeptech with IP Strategy

#48: Kurt Höller & Joy Cürten EIT - Health & The International Healthtech Revolution

#47: Sebastien Groyer - 7 Tales from 20 years of Deep Tech Life Science Venture Capital Investment

#46: Wolfgang Kienreich - An Introduction to Know-Center: How Artificial Intelligence Will Change all Industries

#45: Jama Nateqi - 5 Habits of Successful Entrepreneurs

#44: Tero Weckroth - Private and Public Investments - Similarities and Differences from the Crowdfunding and Angel Perspective

#43: Tilmann Buerckstuemmer and Thomas Moser - Gene-Editing - The Next Game-Changing Technology?

#42: Johannes Sarx and Philipp Hainzl - LISA - Life Science in Austria

#41: Christoph Lengauer - The 7 Key Success Factors of Building Great Life Science Companies.

#40: beaconsmind - Max Weiland About Starting a Company and get it to a Dual Listing in only 6 years

#39: All You Need to Know About the Novel €95.5 Billion Horizon Europe Programme...

#38: Dusica Lukac - The Magic of Corporate Finance

#29: Ultraleap. Digital Worlds that Feel Human.